Novel Coronavirus (SARS-CoV-2/COVID-19)
Hospitals and health systems are protecting people, advancing access and equity, and promoting community health. Join in us telling the story.
Medicaid enrollment for fiscal year 2021 is expected to jump 8.2%, with state spending to accelerate by 8.4%, according to data from 42 state Medicaid directors and compiled by the Kaiser Family Foundation.
The Federal Reserve will host a webinar Oct. 21 at 2 p.m. ET to help borrowers learn about the Main Street Lending Program and provide an opportunity for borrowers to get answers to specific questions on the program and its operations. Questions are to be submitted in advance to questions@askthefed…
The Department of Health and Human Services and the Department of Defense awarded $481 million to Cue Health Inc. to expand production of a point-of-care COVID-19 molecular test with capabilities to produce results in 20 minutes.
The National Institutes of Health Oct. 13 announced a study designed to identify promising COVID-19 therapies and investigational drugs that merit larger clinical trials.
The Centers for Disease Control and Prevention added vaccine information to its COVID-19 webpage.
The Food and Drug Administration Oct. 13 issued and immediately implemented enforcement policy for modifications to FDA-cleared molecular influenza and RSV tests during the COVID-19 public health emergency to expand access to certain FDA-cleared molecular tests for detecting and identifying flu…
The NFL Players Association and AHA teamed up on a PSA to encourage individuals to wear masks to protect against COVID-19.
Ask Your Representatives to Sign ‘Dear Colleague’ Letter Urging HHS to Reinstate June COVID-19 Provider Relief Fund Reporting Requirements
Please contact your representatives today and ask them sign on to a “Dear Colleague” letter to the Department of Health and Human Services (HHS) urging it…
The Centers for Disease Control and Prevention Oct. 22 at 2 p.m. ET will host a Clinician Outreach and Communication Activity webinar on improving clinicians’ understanding the relationship between COVID-19 and the concerns of people who use drugs or who have a substance use disorder.